|
(V1500) |
Nocturnal hypoxemic burden in ambulatory patients with atrial fibrillation: a disease-orientated assessment of sleep-disordered breathing severity |
| |
|
D. Linz, M. Baumert, K. Kadhim, D. McEvoy, P. Sanders (Adelaide, AU) |
|
|
Diskussion |
|
(V1501) |
Risk prediction of atrial fibrillation in the community combining biomarkers and genetics |
| |
|
C. S. Börschel, A. Ohlrogge, B. Geelhoed, T. J. Niiranen, A. Havulinna, T. Palosaari, S. Blankenberg, T. Zeller, V. Salomaa, R. Schnabel, für die Studiengruppe: BiomarCaRE (Hamburg; Helsinki, FI) |
|
|
Diskussion |
|
(V1502) |
Epigenetic regulation of TREK-1 K+channels in atrial fibrillation |
| |
|
P. Lugenbiel, P. Syren, A.-K. Rahm, P. Schweizer, T. Wieder, F. Wenz, K. Govorov, H. A. Katus, D. Thomas (Heidelberg, Mannheim, Hamburg) |
|
|
Diskussion |
|
(V1503) |
Metabolomics in Translational Medicine – A Link between Acyl-carnitines and Atrial Fibrillation |
| |
|
J. Krause, A. Löser, F. Ojeda-Echevarria, R. Schnabel, S. Blankenberg, T. Eschenhagen, T. Christ, J. Stenzig, T. Zeller, für die Studiengruppen: BiomarCaRE, AFHRI-B (Hamburg) |
|
|
Diskussion |
|
(V1504) |
Inactivation of HDAC2 attenuates ultrastructural remodeling in CREM-IbΔC-X transgenic mice, a mouse model of spontaneous onset atrial fibrillation |
| |
|
J. S. Schulte, S. Hamer, M. D. Seidl, E. Wardelmann, F. U. Müller (Münster) |
|
|
Diskussion |
|
(V1505) |
Gq/G11-mediated mechanotransduction and signaling promote atrial fibrillation |
| |
|
K. Wöltje, J. Schecker, N. Wilck, V. Stangl, K. Stangl, T. Althoff (Berlin) |
|
|
Diskussion |
|
(V1506) |
A promising novelty for antiarrhythmic therapy: doxapram inhibition of TASK-1 K+ channels suppresses atrial fibrillation in a large animal model |
| |
|
C. Schmidt, F. Wiedmann, C. Beyersdorf, Z. Zhao, H. Lan, I. El-Battrawy, X. Li, M. Kraft, A. Ratte, S. Lang, G. Szabó, M. Karck, X. Zhou, I. Akin, M. Borggrefe, D. Thomas, W. E. Haefeli, N. Decher, H. A. Katus (Heidelberg, Mannheim, Marburg) |
|
|
Diskussion |
|
(V1507) |
Effect of remote ischemic preconditioning on electrophysiological parameters in non-valvular paroxysmal atrial fibrillation: randomized, controlled clinical trial (RIPPAF-study) |
| |
|
J. Kosiuk, K. Langenhan, C. Stegmann, T. Uher, T. Uhe, N. Dagres, B. Dinov, S. Kircher, P. Sommer, L. Bertagnolli, A. Bollmann, G. Hindricks (Köthen, Leipzig, Celle, Bad Oeynhausen) |
|
|
Diskussion |
|
(V1508) |
Comparison of rhythm control vs. rate control strategy for patients with atrial fibrillation complicated with heart failure in the era of catheter ablation: a pooled analysis of 3261 randomized data |
| |
|
S. Chen, K. R. J. Chun, B. Schmidt (Frankfurt am Main) |
|
|
Diskussion |